Kristine Bernard

Statistics

Publications

Citations

554

H-Index

Active since

2011

Affiliations

AMAG Pharmaceuticals (United States)(Current)

McGill University

The University of Texas MD Anderson Cancer Center

Johns Hopkins University

Johns Hopkins Medicine

Kristine Bernard is an author at AMAG Pharmaceuticals (United States) specializing in iron chelation therapy, iron deficiency disorders, and iron deficiency.

Publications per year

2011–2018

Publications

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

N. Franklin Adkinson, William Strauss, Iain C. Macdougall et al. · American Journal of Hematology · 2018 · 127 citations · Full text

Medicine, Hematology, Internal Medicine +15

Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia

Sarah Acaster, Rene Dickerhoof, Kendra DeBusk et al. · Health and Quality of Life Outcomes · 2015 · 97 citations · Full text

Medicine, Hematology, Internal Medicine +17

Antioxidants reveal an inverted U‐shaped dose‐response relationship between reactive oxygen species levels and the rate of aging in <i>Caenorhabditis elegans</i>

David Desjardins, Briseida Cacho‐Valadez, Ju‐Ling Liu et al. · Aging Cell · 2016 · 93 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

David J. Hetzel, William Strauss, Kristine Bernard et al. · American Journal of Hematology · 2014 · 78 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron

Saroj Vadhan‐Raj, William Strauss, David C. Ford et al. · American Journal of Hematology · 2013 · 76 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

1–5 of 10